Project Grant W81XWH2211087
Award Date
9/15/22
Completion Date
9/14/25
Dollars Obligated
$783K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
The Department of the Army Medical Command awarded Vanderbilt University a $1.6 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research into Modulation of Lung and Bone Microenvironments to Treat Breast Metastases. The three-year award beginning September 15, 2022 will fund investigation into medical solutions for breast cancer that has metastasized to the lungs and bones. As part of the Military Medical Research and Development...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center a $1.4 million cooperative agreement from September 15, 2021 to September 14, 2024 under the Military Medical Research and Development program (CFDA 12.420). The award will support Vanderbilt's Kidney Cancer Clinical Trials Consortium to conduct clinical trials investigating medical solutions for kidney cancer through the Military Medical Research and Development program's goals of transforming military and...
This federal Project Grant award for $962,697.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Vanderbilt University Medical Center (VUMC) to investigate the role of integrin beta1 as a mediator of clear cell renal cell carcinoma metastasis and growth. The award, which began on September 1, 2024 and will run through August 31, 2028, will fund advanced biomedical research initiatives focused on transforming...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
The Department of the Army Medical Command awarded a $700,000 Cooperative Agreement to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 15, 2024 to September 14, 2026, supports the KIDNEY CANCER CLINICAL TRIALS CONSORTIUM project to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public....
The Department of the Army Medical Command awarded a $1,520,818 Project Grant to Southern Research Institute under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2025 to develop rank signaling inhibitors for treating breast cancer bone metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...